Mr. Stephen Mulvany:

There are a couple of things. We can check the actual specific details while we are here. There is an agreement with the organisation called IPHA, which is the representative body of some pharmaceutical companies, which allows us attract an additional amount of a rebate. Also, as I understand it, we settled a particular contract with a number of suppliers. There are three or four elements to it, on which I can come back to the Deputy before the meeting is over.